OsteoSee

Osteoporosis Screening Technology

Health Tech & Life Sciences
Non Active, Jan 2022 ceased to operate
Seed Herzliya, Israel Founded 2017
LinkedIn
Last updated 2026-06-18
Total raised
Last: 2017-12
Stage
Seed
Founded
2017
Headcount
1
HQ
Herzliya, Israel
Sector
Health Tech & Life Sciences

About

OsteoSee is a clinical-stage company focused on bringing bone-health screening and monitoring to the primary care clinic and the home. The company is developing a comprehensive solution to accurately manage bone health anytime, anywhere. OsteoSees new 360 bone health solution enables quick, frequent, and affordable bone mineral density (BMD) measurements easily via the wrist or pelvis, either in a physicians office or at home. The company uses proprietary parametric electrical impedance tomography (pEIT) technology to provide primary care physicians with a tabletop system for rapid diagnosis and frequent in-office monitoring. OsteoSee Home also produces a wristband system connected to a smartphone, enabling remote monitoring and self-monitoring of osteoporosis treatment and potential drug-induced osteoporosis. OsteoSees two technologies address the enormous unmet need for screening and diagnosing osteopenia and osteoporosis at the point of care, including at primary care clinics and at home, and can help transform the quality of life for osteoporotic patients worldwide.

Funding history · 1 round · — total

2017-12
Undisclosed

Q&A

What is OsteoSee's primary focus?
OsteoSee is a clinical-stage company focused on bringing bone-health screening and monitoring to primary care clinics and homes, developing solutions for accurate bone health management.
What technology does OsteoSee utilize for bone health screening?
OsteoSee uses proprietary parametric electrical impedance tomography (pEIT) technology for rapid diagnosis and frequent in-office monitoring of bone mineral density.
How does OsteoSee enable remote monitoring of bone health?
OsteoSee Home offers a wristband system connected to a smartphone, allowing for remote and self-monitoring of osteoporosis treatment and potential drug-induced osteoporosis.
When was OsteoSee founded?
OsteoSee was founded in December 2017.
What is the current status of OsteoSee?
OsteoSee is currently inactive, having ceased operations in January 2022.
Which investor participated in OsteoSee's funding round in December 2017?
eHealth Ventures participated in OsteoSee's funding round in December 2017.
In which country is OsteoSee headquartered?
OsteoSee is headquartered in Herzliya, Israel.

Team · 2

Founder · Co-Founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcarePatient Remote MonitoringMedical DevicesDiagnostics DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B2CB2CB2B

Highlights

1 PatentsVerified

Tags

remote-monitoringdigital-healthcareclinicsdoctorsdiagnosticsmedical-technologiesscreeningboneosteoporosismonitoringmhealthnon-invasivehome-carewearable
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

LinkedInlinkedin.com/company/35601491

Identifiers & details

Founded2017-12
Employees (exact)1
Status reasonNon Active, Jan 2022 ceased to operate